Drug interaction study of vimseltinib in healthy men
Treatments studied
This study is for healthy men to see how a new drug called vimseltinib affects a protein in your body that helps remove other drugs. Participation will help your doctors understand how to use this drug safely in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male and in generally good health.
- Your body mass index (BMI) should be between 18 and 32.
- You must have normal blood and urine test results as evaluated by the study doctor.
- You must not have any significant medical conditions (such as heart, kidney, or liver disease).
- You must be willing to follow the study protocol and attend all visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a new medicine (Flonoltinib Maleate) interacts with other drugs in healthy adults. It helps doctors understand safe dosing and potential effects before the medicine is tested in patients.
This study tests how another drug (carbamazepine) affects the amount of an investigational drug (verducatib) in the blood of healthy men. It helps determine if the drugs can be given together safely and how they interact.
This study checks how befotertinib, an experimental cancer drug, interacts with other drugs in healthy people. It helps make sure the drug is safe and works well when taken with other medicines.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This study tests how a new investigational medicine affects the way your body handles two common drugs: a blood thinner (dabigatran) and a cholesterol-lowering medicine (rosuvastatin). It helps researchers understand if the new medicine is safe to use together with these drugs.
This study looks at how a medicine called velzatinib affects people with moderate or severe kidney problems compared to those with normal kidney function. The goal is to see if the medicine is safe and how it is processed by the body.
Hear when a new Healthy Male Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.